Elekta’s Leksell Gamma Knife Perfexion Earns Nearly Perfect Score in 2011 KLAS Radiation Therapy Report
ATLANTA, Dec. 9, 2011 /PRNewswire/ — With a score of 94.4 out of 100, Elekta’s Leksell Gamma KnifeÂ® Perfexion(TM) is “practically perfect in every way,” ranking at the top among six advanced radiation therapy systems, according to KLAS research firm’s recently released customer survey, Radiation Therapy 2011: A Dose of New Technology. The Elekta Infinity(TM) radiation treatment system garnered the #2 ranking with a score of 84.4, improving its score over the 2010 report.
The 2011 KLAS report – the result of interviews with 213 U.S. provider organizations – referenced respondents’ regard for the Perfexion system’s technological sophistication, making “treating very complicated tumors in a difficult spot easy for providers,” and for the radiosurgery platform’s unprecedented uptime statistics. The report summarized customer opinion by noting: “The speed, accuracy, reliability, and sophistication of the treatments all came together for the Gamma Knife Perfexion to earn the highest score in the study by a 10-point margin.”
Gamma KnifeÂ® surgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease – cancer that has traveled to the brain from elsewhere in the body. The system delivers thousands of low-intensity radiation beams to one or more targets in a single session. Leksell Gamma Knife Perfexion provides even greater speed and ease of use than previous versions, especially for treating multiple metastases.
Supported by three decades of clinical practice in both neurosurgery and radiation oncology departments, more than 50,000 patients each year are treated with Gamma Knife surgery.
*Radiation Therapy 2011: A Dose of New Technology, Â© November, 2011 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.